newdrugapprovals.org
Celgene makes good start to 2013 as Revlimid hits $1 billion
April 26, 2013Celgene Corp has posted a healthy set of financials for the first quarter despite a 4.1% decline in net income to $410.2 million, as product sales increased 15% to $1.43 billion. rea…